BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 35525079)

  • 1. Novel bifluorescent Zn(II)-cryptolepine-cyclen complexes trigger apoptosis induced by nuclear and mitochondrial DNA damage in cisplatin-resistant lung tumor cells.
    Wang ZF; Zhou XF; Wei QC; Qin QP; Li JX; Tan MX; Zhang SH
    Eur J Med Chem; 2022 Aug; 238():114418. PubMed ID: 35525079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel glycosylation zinc(II)-cryptolepine complexes perturb mitophagy pathways and trigger cancer cell apoptosis and autophagy in SK-OV-3/DDP cells.
    Zhou Z; Du LQ; Huang XM; Zhu LG; Wei QC; Qin QP; Bian H
    Eur J Med Chem; 2022 Dec; 243():114743. PubMed ID: 36116236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondria-localizing curcumin-cryptolepine Zn(II) complexes and their antitumor activity.
    Qin LQ; Liang CJ; Zhou Z; Qin QP; Wei ZZ; Tan MX; Liang H
    Bioorg Med Chem; 2021 Jan; 30():115948. PubMed ID: 33360578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel zinc(II)-curcumin molecular probes bearing berberine and jatrorrhizine derivatives as potential mitochondria-targeting anti-neoplastic drugs.
    Zhang SH; Wang ZF; Tan H
    Eur J Med Chem; 2022 Dec; 243():114736. PubMed ID: 36115208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imaging and therapeutic applications of Zn(ii)-cryptolepine-curcumin molecular probes in cell apoptosis detection and photodynamic therapy.
    Qin QP; Wei ZZ; Wang ZF; Huang XL; Tan MX; Zou HH; Liang H
    Chem Commun (Camb); 2020 Apr; 56(28):3999-4002. PubMed ID: 32154536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complexes of Zn(II) with a mixed tryptanthrin derivative and curcumin chelating ligands as new promising anticancer agents.
    Wang ZF; Nong QX; Yu HL; Qin QP; Pan FH; Tan MX; Liang H; Zhang SH
    Dalton Trans; 2022 Mar; 51(13):5024-5033. PubMed ID: 35274641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Precisely Assembled Nanoparticles against Cisplatin Resistance via Cancer-Specific Targeting of Mitochondria and Imaging-Guided Chemo-Photothermal Therapy.
    Yang GG; Pan ZY; Zhang DY; Cao Q; Ji LN; Mao ZW
    ACS Appl Mater Interfaces; 2020 Sep; 12(39):43444-43455. PubMed ID: 32883070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytotoxicity and cell cycle effects of the plant alkaloids cryptolepine and neocryptolepine: relation to drug-induced apoptosis.
    Dassonneville L; Lansiaux A; Wattelet A; Wattez N; Mahieu C; Van Miert S; Pieters L; Bailly C
    Eur J Pharmacol; 2000 Dec; 409(1):9-18. PubMed ID: 11099695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cisplatin induces a mitochondrial-ROS response that contributes to cytotoxicity depending on mitochondrial redox status and bioenergetic functions.
    Marullo R; Werner E; Degtyareva N; Moore B; Altavilla G; Ramalingam SS; Doetsch PW
    PLoS One; 2013; 8(11):e81162. PubMed ID: 24260552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cisplatin preferentially binds mitochondrial DNA and voltage-dependent anion channel protein in the mitochondrial membrane of head and neck squamous cell carcinoma: possible role in apoptosis.
    Yang Z; Schumaker LM; Egorin MJ; Zuhowski EG; Guo Z; Cullen KJ
    Clin Cancer Res; 2006 Oct; 12(19):5817-25. PubMed ID: 17020989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cu(ii)-TACN complexes selectively induce antitumor activity in HepG-2 cells via DNA damage and mitochondrial-ROS-mediated apoptosis.
    Liu M; Song XQ; Wu YD; Qian J; Xu JY
    Dalton Trans; 2020 Jan; 49(1):114-123. PubMed ID: 31793575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zn(II)-bis(cyclen) complexes and the imaging of apoptosis/necrosis.
    Oltmanns D; Zitzmann-Kolbe S; Mueller A; Bauder-Wuest U; Schaefer M; Eder M; Haberkorn U; Eisenhut M
    Bioconjug Chem; 2011 Dec; 22(12):2611-24. PubMed ID: 22040278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Profiling of apoptosis- and autophagy-associated molecules in human lung cancer A549 cells in response to cisplatin treatment using stable isotope labeling with amino acids in cell culture.
    Wang Z; Liu G; Jiang J
    Int J Oncol; 2019 Mar; 54(3):1071-1085. PubMed ID: 30664195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The DNA intercalating alkaloid cryptolepine interferes with topoisomerase II and inhibits primarily DNA synthesis in B16 melanoma cells.
    Bonjean K; De Pauw-Gillet MC; Defresne MP; Colson P; Houssier C; Dassonneville L; Bailly C; Greimers R; Wright C; Quetin-Leclercq J; Tits M; Angenot L
    Biochemistry; 1998 Apr; 37(15):5136-46. PubMed ID: 9548744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cryptolepine and aromathecin based mimics as potent G-quadruplex-binding, DNA-cleavage and anticancer agents: Design, synthesis and DNA targeting-induced apoptosis.
    Yuan JM; Wei K; Zhang GH; Chen NY; Wei XW; Pan CX; Mo DL; Su GF
    Eur J Med Chem; 2019 May; 169():144-158. PubMed ID: 30875505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A cyclopalladated complex interacts with mitochondrial membrane thiol-groups and induces the apoptotic intrinsic pathway in murine and cisplatin-resistant human tumor cells.
    Serrano FA; Matsuo AL; Monteforte PT; Bechara A; Smaili SS; Santana DP; Rodrigues T; Pereira FV; Silva LS; Machado J; Santos EL; Pesquero JB; Martins RM; Travassos LR; Caires AC; Rodrigues EG
    BMC Cancer; 2011 Jul; 11():296. PubMed ID: 21756336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cryptolepine inhibits melanoma cell growth through coordinated changes in mitochondrial biogenesis, dynamics and metabolic tumor suppressor AMPKα1/2-LKB1.
    Pal HC; Prasad R; Katiyar SK
    Sci Rep; 2017 May; 7(1):1498. PubMed ID: 28473727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strong in vitro and vivo cytotoxicity of novel organoplatinum(II) complexes with quinoline-coumarin derivatives.
    Qin QP; Wang ZF; Huang XL; Tan MX; Zou BQ; Liang H
    Eur J Med Chem; 2019 Dec; 184():111751. PubMed ID: 31593828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticancer Activity and Mode of Action of Cu(II), Zn(II), and Mn(II) Complexes with 5-Chloro-2-
    Gai S; He L; He M; Zhong X; Jiang C; Qin Y; Jiang M
    Molecules; 2023 Jun; 28(12):. PubMed ID: 37375431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of the Apoptosis Inducing and β-catenin Silencing by Tetradentate Schiff Base Zinc(II) Complex on the T-47D Breast Cancer Cells.
    Majd MH; Guo X
    Anticancer Agents Med Chem; 2023; 23(15):1740-1746. PubMed ID: 37171012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.